Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Clinical trial NCT01210222 · COMPLETED

Trial details

NCT number: NCT01210222
Sponsor: Gynecologic Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation Endometrial Serous Adenocarcinoma Endometrioid Stromal Sarcoma Recurrent Uterine Corpus Carcinoma

Start date: 2011-06-06
Primary completion: 2016-07-16
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.